Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 15, 2007British Journal of Clinical PharmacologyOpen Access

Development of oral anticoagulants

View Full Paper
Ask AI
Bookmark
Share

Design

Editorial

Authors

QMQing MaNingbo University

Discussion

Loading...

Member takes

Overview

Warfarin remains foundational for thrombosis management; extends long-term safety data for vitamin K antagonists in clinical use.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Qing Ma (2007) studied this question.

synapsesocial.com/papers/6a992c98d98b03152a362a6dhttps://doi.org/10.1111/j.1365-2125.2007.02898.x

Topics

Anticoagulation in AF
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee Replacement2003 · 321 citations
  2. 2Warfarin: almost 60 years old and still causing problems2006 · 337 citations
  3. 3American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy2003 · 915 citations
  4. 4Pharmacokinetic Profile of the Oral Direct Thrombin Inhibitor Dabigatran Etexilate in Healthy Volunteers and Patients Undergoing Total Hip Replacement2005 · 296 citations
  5. 5Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases2006 · 106 citations